HuBei NengTer Technology released its performance for the first half of the year, with a net profit attributable to the parent company of 339 million yuan, an increase of 496.36%
HuBei NengTer Technology released its semi-annual report for 2025, with operating revenue of 5.229 billion yuan, a year-on-year decrease of 16.09%. The net profit attributable to the parent company was 339 million yuan, a year-on-year increase of 496.36%. The net profit after deducting non-recurring gains and losses was 411 million yuan, a year-on-year increase of 759.36%. The basic earnings per share were 0.1288 yuan. The wholly-owned subsidiary's vitamin E and pharmaceutical intermediate business performed well, contributing approximately 447 million yuan in profit
According to the Zhitong Finance APP, HuBei NengTer Technology (002102.SZ) released its semi-annual report for 2025, showing an operating income of 5.229 billion yuan, a year-on-year decrease of 16.09%. The net profit attributable to shareholders of the listed company was 339 million yuan, a year-on-year increase of 496.36%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 411 million yuan, a year-on-year increase of 759.36%. The basic earnings per share were 0.1288 yuan.
During the reporting period, the vitamin E and pharmaceutical intermediate business of its wholly-owned subsidiary, HuBei NengTer Technology Co., Ltd., maintained good operating conditions, bringing the company a profit of approximately 447 million yuan, with significant growth in operating performance compared to the same period last year
